Sergei Doulatov received his B.S. from the University of California, Los Angeles under the mentorship of Drs. Jeff F. Miller and Peggy Cotter, and his Ph.D. from the University of Toronto under the mentorship of Dr. John E. Dick, where he established the “roadmap” of human hematopoietic stem and progenitor cell populations enabling their purification and molecular characterization. He then joined the lab of Dr. George Q. Daley at the Harvard Medical School as a Howard Hughes Medical Institute Fellow of The Helen Hay Whitney Foundation, where he developed strategies to generate hematopoietic stem cells from pluripotent stem cells. The Doulatov lab at the University of Washington studies human hematopoiesis in health and disease by leveraging primary human and pluripotent stem cell models. In addition to the NIH Director’s New Innovator Award, he is the recipient of the Gilead Research Scholars Award and the NIH Pathway to Independence Award.
Massiel completed her Ph.D. at the University of Rochester in 2016 under the mentorship of James Palis. Her thesis work focused on the regulation of platelet function during embryonic development. Massiel joined the Doulatov lab in December 2016. Her research focuses on the regulation of autophagy in human hematopoiesis.
Jasper received his B.S. and M.S. in Biomedical Engineering from the University of Southern California. Jasper joined the Doulatov Lab in February 2017. He likes golf and fishing.
Andreea completed her Ph.D. from UC Santa Cruz in 2016 under the mentorship of David Feldheim. Her thesis work focused on the molecular specification of the retinal ganglion cell identity. Andreea joined the Doulatov lab in January 2018. Her research focuses on iPSC models of myelodysplastic syndromes and leukemias.
Courtnee completed her B.S. in Biology at the University of Washington in 2014. After graduating, she spent several years in the laboratory of Dr. David Rawlings at Seattle Children’s Research Institute developing gene therapy strategies to treat several primary immunodeficiencies. She joined the Doulatov lab in June 2018. Her thesis work focuses on SF3B1-mediated aberrant splicing in myelodysplastic syndromes.
Rachel completed her B.S. and M.S. in Molecular and Cellular Biology at the University of Arizona in 2015. As an undergraduate, Rachel worked in the laboratory of Frans Tax at the University of Arizona and Feng-Chun Yang at Indiana University School of Medicine. After graduating, Rachel worked in the laboratory of Andrew Capaldi studying the effectors of the target of rapamycin complex 1 (TORC1). She joined the Doulatov lab in March 2019 and is co-mentored by Brandon Hadland (FHCRC). Her thesis work focuses on differentiation of pluripotent stem cells into hematopoietic stem cells.
Raisa Stolitenko – Lab manager